US-funded global health R&D is advancing innovations that are improving health worldwide, and it is also paying huge dividends for America.
Strategies to accelerate the shift from volume to value
As one of the fastest-rising categories of healthcare costs, pharmaceuticals need to develop a metric that explains pricing.
Why is the shift to value taking so long? And where are the promised results? There's nothing wrong with the model; the problem is in execution and implementation.
Now more than ever, Medicaid MCOs need the right providers in their network.
New analysis details how ‘all in’ provider organizations have to go to reap risk rewards.
As provider organizations prepare for MACRA, they should consider these five workforce and organizational issues.
Success in the value-based market depends on mastering the basics: risk management and care coordination.
Today's market requires a new approach to medical cost management. Learn about common pitfalls and five program must-haves.
Details on the final Call Letter and advice for where plans should place their strategic focus in 2018.
The demand for managed long-term services and support is up, and expected to climb higher. What payers need to know about managing this complex line of business.